Lipid Management in Patients with Diabetes Mellitus

Introduction to Lipid Targets

The American Diabetes Association recommends specific targets for patients with diabetes: Total Cholesterol (TC) < 5 mmol/L, LDL Cholesterol < 2.6 mmol/L (100 mg/dL), Triglycerides (TG) < 1.7 mmol/L (150 mg/dL), and HDL Cholesterol > 1.0 mmol/L (40 mg/dL) for men and > 1.3 mmol/L (50 mg/dL) for women 1, 2, 3

For patients with diabetes who are over 40 years of age without overt CVD but with one or more CVD risk factors, the primary goal is LDL-C < 100 mg/dL (2.6 mmol/L) 1
If LDL-lowering drugs are used, a reduction of at least 30-40% in LDL-C levels should be achieved 1
For patients with overt cardiovascular disease (CVD), an optional lower target of < 70 mg/dL (1.8 mmol/L) is recommended for LDL 2
If drug-treated patients cannot reach these targets on maximum tolerated statin therapy, a reduction of 30-40% from baseline is an alternative therapeutic goal 2

The target for triglycerides is < 150 mg/dL (1.7 mmol/L) 1, 2, 3, 4
Elevated triglycerides are an independent risk factor for cardiovascular disease in diabetic patients 1, 2, 3, 4
In patients with triglycerides 200-499 mg/dL, non-HDL cholesterol (total cholesterol minus HDL) becomes a secondary target with a goal of < 130 mg/dL 1

The target for HDL is > 40 mg/dL (1.0 mmol/L) for men and > 50 mg/dL (1.3 mmol/L) for women 1, 2, 3
Higher HDL levels are associated with lower cardiovascular risk 1, 2, 3
Women with diabetes should aim for higher HDL levels (> 50 mg/dL) compared to men (> 40 mg/dL) 1, 2

Lipid levels should be measured at least annually in adult patients with diabetes, and more often if needed to achieve goals 1, 2
In adults under 40 years with low-risk lipid values (LDL-C < 100 mg/dL, HDL-C > 50 mg/dL, and triglycerides < 150 mg/dL), lipid assessments may be repeated every 2 years 1, 2
Lifestyle modification is the primary intervention, focusing on reduction of saturated fat (< 7% of calories) and cholesterol intake (< 200 mg/day), weight loss (if indicated), increased dietary fiber and physical activity, and avoidance of trans fats 1, 2, 5
Reduction of saturated fat (< 7% of total calories) and cholesterol intake (< 200 mg/day) is recommended 2, 5
Weight loss if overweight or obese is recommended 5
Increased dietary fiber (10-25 g/day) and plant stanols/sterols (2 g/day) is recommended 5
Increased physical activity (at least 150 minutes/week) is recommended 5
Complete avoidance of trans fats is recommended 5

Statins are first-line therapy regardless of baseline lipid levels for LDL reduction 2
Consider adding ezetimibe or bile acid sequestrants if LDL goals not achieved with statins 2
For triglyceride reduction, optimize glycemic control first, then consider fibrates (gemfibrozil, fenofibrate) if TG remains > 150 mg/dL despite glycemic control 3
Niacin is an alternative for triglyceride reduction but may affect glycemic control 3
Monitor liver function tests before and periodically during statin therapy 3
Assess for muscle symptoms and consider CK measurement if symptoms develop 3
Combination of statins with fibrates or niacin may be necessary for mixed dyslipidemia but increases risk of myositis 3
Poor glycemic control can worsen dyslipidemia, particularly triglyceride levels 3